Therapeutic Potential of Plant-Derived Antimicrobial Agents: A Systematic Literature Review

Antimicrobial resistance (AMR) has become a pressing health issue across the globe, making a plethora of traditional antibiotics ineffective against pathogenic microorganisms, fungi, and viruses [1]. The continuous pursuit of the alternative therapeutic agents has been triggered by this crisis in which plant-derived compounds have become a possible solution since they offer a wide variety of bioactive molecules [2]. Traditionally, traditional medicine systems used medicinal plants as curing for chemical infections, inflammation, and other illnesses, although at the time of the modern antibiotics, they were unaware of this, way before the emergence of such drugs [3]. Their therapeutic potential is returning to the spotlight today after serious scientific studies and their action mechanism has been shown to involve membrane disruption, enzyme inhibition and interference with microbial virulence factors [4].

Plants synthesize a wide intermediate metabolites including alkaloids, flavonoid, terpenoids, and phenolic, and demonstrate universal antimicrobial activity [5]. These compounds are known to work together, thus decreasing the chances of resistance rising in contrast to single target synthetic drugs [6]. Furthermore, the issue of antimicrobials of plant origin, in general, is less likely to be associated with adverse effects, which is why it becomes an appealing choice in terms of developing a therapeutic drug [7]. In addition to having direct antimicrobial action some phytochemicals influence host immune responses, increasing the body natural host defense response to infection [8].

Amid these pledges, there are major research gaps, which restrict the adoption of the antimicrobials derived by way of plants. A lot of research is still at in vitro or preclinical phases and lacks clinical validation [9]. The inconsistency of plant composition based on environmental influences, the extraction process and absence of standard procedures, further complicates reproducibility [10]. Moreover, the mechanisms that govern the synergistic action of multi-component plant extract are still incompletely studied and require further research of pharmacological studies [11]. There are regulatory or scalability challenges as well in the integration of plant-based therapies into modern medicine, especially in assuring quality and efficacy [12].

This review was motivated by the pressing urgency to increase attention to AMR and seek alternative ways to move on to sustainable biocompatible solutions to synthetic drugs. The use of antimicrobials produced by plants provides a twofold benefit: providing an answer to the selection of resistant microbes and corresponding with an increasing demand of natural therapeutic agents [13]. This systematic literature review will help the field by enhancing existing knowledge, recognizing key trends, and outlining translational opportunities. Through assessment of antimicrobial activities of phytochemicals, its medicinal use, and some upcoming delivery systems including nanoparticles, the work is a complete basis of research and practical use in the future.

This paper will be structured as follows: Section 2 helps to establish the methodology of literature selection and analysis. In section 3, the results have been presented including research trends, antimicrobial properties of plant compounds, applications in disease treatment, aquaculture and nanotechnology. Section 4 is implications of these findings and 5 is the conclusion with future directions.

2. Methodology

2.1 Review Protocol

This is a systematic review, which is framed to follow PRISMA (Preferred Reporting Items of Systematic Reviews and Meta-Analyses) guidelines to make it methodologically robust and transparent [14]. The search in the literature was done in five largest databases, which were chosen based on their applicability to both biomedical and pharmacological studies. PubMed was selected based on its comprehensive dealings with peer-reviewed medical articles and Web of Science and Scopus based on their multidisciplinary nature and excellent citation capabilities. The other sources they included were ScienceDirect and SpringerLink, as they are considered to have high-quality research articles on the life sciences and chemistry. Google scholar was utilized as an aid tool to fetch more grey contents and current publications that may not have been uploaded in major bases.

The search terms were a blend of the keywords which concerned plant-derived antimicrobial agents and their potential to treat microbes and to avoid review articles and meta-analyses and therefore to concentrate on research articles. Indicatively, the titleabstractkeywords search was used in Web of Science and Scopus of the MeSH terms like Plant extracts and antimicrobial agents with Boolean operators. The filters used were ScienceDirect and SpringerLink to narrow down the results to research articles.

2.2 Dimensions of Research and Analysis.

The review is based on seven critical dimensions to critically analyze the therapeutic potential of plant-derived antimicrobials. Such dimensions include the activity of phytochemicals as an antimicrobial agent, treatment of a particular disease and the use of plant-based nanoparticles in improving medication delivery. Combative relations between plant products and standard antibiotics are investigated to find out more combinatory measures of get-over resistance. The method of phytochemical analysis is analyzed to identify the progress in the identification and characterization of compounds. Finally, the use of plant antimicrobials in aquaculture is discussed as a new field in response to microbial infections in aquatic environment.

2.3 Inclusion and Exclusion Criteria.

The inclusion criteria were that the studies focused on plant-derived compounds with proven antimicrobial activity, that they had experimental or clinical results, and were written in the English language. The period was not limited to include both historical and more current studies, however, the articles, abstracts of conferences, and research without information on methods were not included. Artificial analogs of plant compounds were also not considered as long as the study did not have a precise therapeutic interest.

2.4 Study Selection Process

The first search resulted in 1,212 records, 212 of which were automatically duplicated. Screening titles and abstracts, 674 irrelevant studies were eliminated. A total of 143 articles were assessed in full-text to exclude 23 studies that failed to pass the eligibility criteria and left 120 studies to be analyzed (Figure 1). This process is depicted in the PRISMA flowchart that explains why certain phases are excluded.

Figure 1. PRISMA flowchart of study selection

Possible sources of bias are database selection bias since not all niche journals are covered in large databases, and the bias of language because only non-English studies were excluded. To overcome these, additional searches were conducted, and results were compared in various sources.

3. Results

3.1 Research Trends

Figure 2. Research trends in the domain of therapeutic potential of plant-derived antimicrobial agents

Trends in the number of publications can be used to analyze the revival of interest in plant-derived antimicrobial agents in the last 10 years. Although in the initial days of the study (before 2016) the literature of the study is focused on 43 studies, it was observed that there was a gradual rise in the number of works since 2020, with the highest number of 29 works in 20252026. This time scale trend indicates a resurgence of scientific interest in phytochemical-based antimicrobial agents, presumably in response to the intensifying worldwide problem of antimicrobial resistance. The statistics support the fact that the basic research on antimicrobial qualities of plant-derived compounds was fully developed prior to 2016, which accepted 29 studies and further research has been actively developed in the field of therapeutic use as well as in innovative methods of delivery.

The spread of the research topics has diverse evolution patterns. Research on potential therapeutic uses of medicinal plants has been rapidly accelerating since 2020, overtaking basic antimicrobial research by 2025–2026. Such a trend can be seen as a translational change in the in vitro characterization to clinical applications. Modified forms of nanoparticles like the use of the nanoparticle derived from plants and nanovesicles are novel concepts, only found after 2023, and this is why nanotechnology has become a part of phytochemical studies. The long history of phytochemical analysis research over the years highlights the persistence of the merits of compound identification and characterization as the foundation of the discipline.
The antimicrobial beneficial effects of the compounds found in plants are investigated in the following section

3.2 Antimicrobial Properties of Plant-Derived Compounds

Plant-derived compounds have various antimicrobial activities as they do not only inhibit the growth and propagation of a pathogen but also cause the immune system of hosts to change. These phytochemicals have been shown to alter several microbial pathways in the included studies, therefore they are less likely to develop resistance as compared to single-target synthetic antibiotics in developing antibiotic resistance.

3.2.1 Broad-Spectrum Antimicrobial Activity

Plant extracts and essential oils are effective against Gram-positive, Gram-negative bacteria, fungi and mycobacteria. Notably, Cinnamomum tamala essential oil depicts great antifungal and antioxidative effects [15], and the extract of Aegle marmelos has a broad range of clinical pathogen activity [16]. Antibacterial effects of polyphenols and flavonoid include those produced by Morus species, which obstructs the biomembrane of microbial cells, and blocking the formation of biofilms [17]. On the same note, quinonoid products of Citrullus Lanatus seeds also have potent antitubercular effects against multi-drug resistant Mycobacterium tuberculosis infectious strains [18].

3.2.2 Mechanisms of Action

The use of plant antimicrobials uses various models to attack the pathogens. Efflux pump inhibition which is seen in Staphylococcus aureus exposed to a new plant-based antibacterial agent [19], inhibits drug efflux in the microbes and increases the retention of the antibiotics. Plant extracts can be used synergistically with traditional antibiotics to enhance treatment effects against resistant strains, e.g., Mentha piperita essential oil in combination with amoxicillin [20]. Also, phytochemicals such as polyacetylenes interfere with quorum sensing decreasing the production of virulence factors in Pseudomonas aeruginosa [21].
3.2.3 Classes of Phytochemicals and their uses.

Table 1 groups the antimicrobial attributes of plant-derived compounds per their chemical families and intended medicines.
 

Table 1. Classification of Plant-Derived Antimicrobial Compounds by Chemical Class and Activity

3.2.4 Challenges and Limitations

Plant-derived antimicrobials face some problems, such as variability in their effects due to variations in plant production and extraction processes [29]. The minimum historical levels (MICs) of certain substances, including Senna alata bark, have been better than the manmade medications, making it impossible to use clinically [30]. Moreover, phytochemical analysis does not have standardized methods of conducting the study and so it is difficult to be replicated across studies [31].

The report on Methylobacterium radiotolerans endophytes [32] emphasizes non-plant based antimicrobial activity, which indicates that the ecological setting to discover bioactive compounds is broader.

The section highlights the complex antimicrobial potential of compounds of plant origin and also appreciates the necessity of additional research to overcome the current shortcomings.

3.3 Medical applications of the Plants in medicine.

Medicinal plants have therapeutic potential beyond their antimicrobial properties, and include a wide range of pharmacological processes which have been used in traditional and modern medicine. Recent reports indicate their effectiveness in treating infectious diseases, chronic diseases, and even emerging viral infections, and by doing this, plant-derived compounds are proving to be very useful in therapeutics.

3.3.1 Broad-Spectrum Therapeutic Applications

The therapeutic value of the medicinal plants is remarkable in terms of the treatment of the diseases since they find application in various spheres of treatment. An example is Persea americana peptides, which are antimicrobial and anticancer agents due to their computational and experimental demonstrations [33]. Likewise, Atractylodes lancea exhibits immunomodulatory and anti-inflammatory activities, and can be used to treat autoimmune and metabolic conditions [34]. Plant-derived compounds have been of specific interest regarding the antiviral potential, with research findings improving on bioactive molecules of Citrullus colocynthis and other plants that prevent viral entry and proliferation [35], [36].

3.3.2.2 Mechanisms of Therapeutic Effects.

Medicinal plants have a therapeutic impact or act via a variety of molecular pathways. Flavonoids, e.g., in Rosa canina, regulate oxidative stress and inflammatory processes, providing a protective effect in skin diseases [37], [38]. Polyalthia species alkaloids disrupt cancer cell growth through protein conformation changes, and gene expression [39], whereas terpenoid lactones produced by several plants have antitumor properties that induce apoptosis in cancer cells that are resistant to antibiotics [40]. Moreover, the nanoparticles of plants, like carica papaya, have anti-inflammatory activity due to their ability to control cytokine secretion [41].

3.3.3 The clinical and potential translation Clinical and Translational Potential.

A number of studies highlight the translational capability of therapeutics derived out of plants, however, issues of in clinical adoption persist. The extracts of holarrhena floribunda are antibacterial and exhibit antimalarial effects in preclinical models, but these effects are still pending validation on dosing and safety profiles [42]. On the same note, Melaleuca quinquenervia essential oil has been shown to be gastroprotective in the instance of peptic ulcer, although studies in humans would need to be conducted to establish efficacy [43]. Blending conventional knowledge and contemporary drug discovery methods like in the case of Tamarindus indica and Sauropus androgynus offer an avenue towards the generation of standardised plant-based medicine [44], [45].

3.3.4 Synergistic, Multitarget Effects.

One major benefit of plant-derived therapeutics is that they can be used to target's various pathways at the same time. Indicatively, compounds of Millettia pinnata have been shown to have a dual action of antibacterial and anti-inflammatory properties to treat infection and related tissue damage [46]. Other approaches to beat drug resistance include synergistic action of plant extracts and standard drugs, like the increased actions of Andrographis paniculata preparations with chemotherapy agents [47]. It is quite useful in multitarget therapy of complex disease such as cancer and chronic infections where mono-agent therapy is not very effective.

3.3.5 Unclassified Studies

Table 2 did not include the pharmacological potential of catechin [48], as well as the role of plant-derived therapies in the infections of diabetic feet [49], but it still deserves to be mentioned. The wide bioactivity of catechin (antimicrobial and cardioprotective) contributes to the heterogeneity of natural products, and natural products associated with diabetic foot infection demonstrate niche wound care.

Table 2. Therapeutic Applications of Selected Medicinal Plants and Their Bioactive Compounds

3.3.6 Challenges and Future Directions

Regardless of their potential, clinical applications of medicinal plants are fraught with challenges that include inconsistency in bioactive compounds, poor bioavailability, and must also be clinically validated. These challenges are critical to overcome by standardizing extraction procedures and designing new delivery systems including nanoformulations. In addition, it is possible to incorporate computational methods such as PASS-assisted prediction [50] and molecular docking [51] to hasten the process of identifying plant-derived lead compounds to targeted therapies.

This paragraph highlights the immense therapeutic potential of the medicinal plants and the necessity of multidisciplinary efforts on converting traditional knowledge into treatments with therapeutic value in clinics. These properties render plant-derived therapeutics as a prospective source of novel medicines with an untapped potential in meeting unmet medical requirements because of the variety of bioactive compounds and the multitarget effects.

3.4 Nanoparticles and Nanovesicles as plant-derived in Antimicrobial Therapy.

With the advent of nanotechnology, delivery and efficacy of plant-derived antimicrobial agents have become groundbreaking with solutions to the problem of low bioavailability and non-specific targeting being provided. Plant-based nanoparticles and nanovesicles are a novel type of therapeutic carriers that imposes the biocompatibility of natural products on the accuracy of nanoscale drug delivery systems.

3.4.1 Classification and Applications

The plant-based nanomaterials can be broadly classified into metallic nanoparticles, carbon-based nanostructures, and biological nanovesicles, which have different antimicrobial effects and find different uses. Phytochemicals synthesize silver nanoparticles that have potent antibacterial properties which disrupt microbial cell membrane and produce reactive oxygen species [52]. Graphene oxide nanoparticles obtained using Monotheca buxifolia show hemocompatibility and antibacterial properties and might have biomedical uses [53]. Exosome-like biological nanovesicles, e.g., exosomes in Carica papaya, regulate inflammation and have the ability to transport bioactive molecules to specific tissues [41].

3.4.2. Mechanisms of Antimicrobial Action

The antimicrobial effect of plant-based nanoparticles has various modes of action. Metal nanoparticles such as silver work through ion release which disrupts microbial electron transport and replication of DNA [52]. Nanomaterials such as graphene oxide, which are made of carbon and physical damage the membranes of bacteria via sharp edges and oxidative pressure [53]. Instead, plant nanovesicles utilize biomimetic approaches to increase drug absorption and control hostpathogen interactions [54]. Such mechanisms tend to be synergistic to the inherent antimicrobial activity of the phytochemicals incorporated in the synthesis of nanoparticles, producing synergistic effects against drug resistant microorganisms.

Table 3. Taxonomy of Plant-Derived Nanoparticles and Their Antimicrobial Applications

3.4.3 Advantages and Challenges

Plant nanoparticles have a number of benefits as compared to synthetic nanoparticles, such as decreased toxicity, environment-friendly production, and increased biocompatibility. Plant extracts Depending on plant extracts enable the green synthesis of silver nanoparticles without the harsh chemical reducing agents and capping with natural substances to stabilize the nanoparticles [52]. Nonetheless, there are still some issues like batch-to-batch fluctuation in plant extracts, commercial viability of production, and long-term toxicity issues. Clinical translation requires standardization of synthesis protocols and intensive in vivo safety evaluations.
3.4.4 Emerging Trends

Recent reports mention the promise of hybrid nanosystems through the integration of vegetal nanosystems with traditional antibiotics or immunomodulators. Indicatively, anti-inflammatory drug-loaded nanovesicles produced using Carica papaya demonstrate a greater tissue penetration in models of chronic infection [41]. In a comparable fashion, the antimicrobial peptides of plants functionalized on graphene oxide nanoparticles show selective action against multidrug-resistant biofilms [53]. The innovations highlight the adaptability of plant-directed nanomaterials in the situation of multifaceted antimicrobial concerns.

The incorporation of plant nanoparticles in antimicrobial therapy will be a paradigm shift in terms of drug delivery in which the therapeutic history of medicinal plants will be versed with the advanced nanotechnology. Future studies are needed to reach optimal synthesis strategies, understand long-term biodistribution and investigate combinatorics to achieve the highest clinical impact.

3.5 Plant-Derived Compounds against disease specifics.

The medicinal use of the plant-based compounds has been propagated to the specific disease treatment, where the multi-faceted nature of pharmacological aspects provides a benefit over standard treatment methods. Recent research proves their effectiveness in the fight of infectious diseases such as COVID-19 and tuberculosis, non-communicable diseases such as cancer and diabetic complications. This part is an evidence synthesis on disease-specific mechanisms and clinical potential.

3.5.1 COVID-19 Antiviral Agents.

Three articles emphasize plant-based compounds as good potential agents against COVID-19. IS54 finds several plant metabolites that have antiviral properties, such as viral entry inhibition by blocking of the ACE2 receptor and viral replication by blocking proteases. These findings can be further supported by IS80 and IS84, which focus on flavonoids and alkaloids of medicinal plants (such as Citrullus colocynthis) as effective SARS-CoV-2 inhibitors. These compounds have dual antiviral, and immunomodulatory properties which mitigates cytokine storms and directly neutralizes viral particles.

3.5.2 Antibacterial Applications

Plant-derived compounds have focused efficacy on bacterial infections. To boost first-line TB drugs against mycobacterial efflux pumps and alterations in the host immune response, IS97 demonstrates that garlic-derived allicin and other phytochemicals promote the use of such drugs. IS87 reports about the effects of natural products such as honey and Aloe vera on wound-healing and antimicrobial effects onto diabetic foot infections where they lower biofilm development and enhance the penetration of antibiotics.

3.5.3 Anticancer Mechanisms

In oncology, IS98 illustrates that carvacrol can create apoptosis in breast cancer cells via activation of tumor suppressor genes and alteration of oxidative stress. The oregano and thyme monoterpenoid is a selective cancer cell killer, leaving normal tissues intact, which could make it an effective adjuvant therapy.

Table 4. Disease-Specific Applications of Plant-Derived Compounds

3.5.4 Insights and Synergies of Mechanicity.

Plant compounds are polypharmacological, so this is the source of their disease specific efficacy. In the case of COVID-19, the set of proteins allowed to bind themselves to viral proteins and host inflammatory pathways at once serves a variety of disease phases. Phytochemicals such as those present in IS97 overcome drug resistance and enhance immune clearance in tuberculosis, by targeting bacterial persistence mechanisms. Multitargeting in multimodal action proves beneficial to complex diseases, such as the example of Carvacrol with IS98, which balances p53, Bax/Bcl-2 ratios, ROS production.

3.5.5 Clinical Translation Challenges

Although preclinical evidence is strong, disparities in drug bioavailability and absence of consistency in dosing schedules hamper conversion to clinical use. IS87 reports that formulation optimization is vital in the preparation of natural products that target diabetic foot infection. In line with this, IS54 underlines the importance of pharmacokinetic investigations to confirm the in vivo effectiveness of COVID-19-preserving phytochemicals.
This discussion demonstrates the promise of plant-based derivatives as precision therapeutics with their multi-mechanistic effects providing an answer to drug resistance and treatment divides in particular diseases. The future studies must emphasize clinical trials and nanoformulation techniques to promote ageing of therapy delivery and treatment.

3.6 Synergistic interactions with the use of both plant-derived compounds and conventional antimicrobials will be discussed here

The investigation of the synergistic actions of the compounds of plant origin and the standard antimicrobial drugs has become one of the promising approaches in the fight against the drug-resistant pathogens. This method takes advantage of the multi-target effects of phytochemicals in addition to the possibility of lowering the dosage of synthetic antibiotics, thereby minimizing side effects and postponing the formation of resistance.

3.6.1 Mechanisms Underlying the Effect of synergy.

The presence of plant compounds facilitate traditional antimicrobials by a variety of pharmacological interactions. The essential oils such as eugenol can be found in clove and this is known to show synergistic action with fluconazole against Candida albicans biofilm by disrupting fungal cell membranes and inhibiting efflux pumps [59]. In a similar manner, the antibacterial action of amoxicillin is enhanced by Mentha piperita essential oil against Gram-negative bacteria by membrane permeabilization coupled with 8-lactamase enzymes inhibition [20]. Such interactions give rise to fractional inhibitory concentration (FIC) indices of less than 0.5 to denote true synergy as opposed to additive effects.

3.6.2 Clinical Implications of Synergistic Combinations

These test combinations have potential uses in the field of therapy beyond what is seen in the laboratory. The research about bioactive plant products [60] also points out their value of usage in antimicrobial chemotherapy whereby plant-based adjuvants reestablish sensitivity of first-line antibiotics in the case of multidrug-resistant infections. Plant-derived novel antimicrobials exhibit greater bactericidal effects during synergistic combinations with bacteriocins that may lead to the application in food preservation and topical antimicrobial preparations [61].

Table 5. Documented Synergistic Combinations of Plant Compounds with Conventional Antimicrobials

3.6.3 Synergy Research difficulties.

The translations of synergistic combinations will have a number of challenges despite being promising. The reliability of standardization of plant extracts is also a problem because the concentrations of active compounds in different batches of the extract and between different techniques of extracting them vary among them. In the research on new antimicrobials [61], it is observed that cellular targets of the compounds of plant origin need to be fully defined to predict and maximize the synergies. Moreover, plant-drug interactions should be closely considered regarding pharmacokinetic compatibility and thus, co-administration should not change the bioavailability of plant-synthetic drugs or cause their toxicity.

The study of plant-antimicrobial synergies is the change of paradigm in the scope of treating infections. Using the complementary activity of natural and synthetic drugs, it is possible to create more effective therapeutic regimens against more and more resistant pathogens. Future research needs to be aimed at clarifying relationships between structure and activity and coming up with standardized procedures in testing synergy to enable clinical translation.
Phytochemical profiling and bioactive characterization of medicinal plants.
The systematic study of phytochemical plants in medicinal plants gives vital knowledge concerning their antimicrobial effects and their therapeutic properties. Recent reports have utilized more sophisticated analysis procedures in detecting and measuring bioactive components and build correlations among phytochemical profiles and the observed antimicrobial actions.

3.7.1 Phytochemical Analysis methodology.

Modern work adopts an integrated approach between chromatographic and spectroscopic procedures to comprehensively characterize phytochemicals. The use of high-performance liquid chromatography (HPLC) and gas chromatography-mass spectrometry (GC-MS) made it possible to detect such components in phenolic acids and flavonoids as well as essential oils in plants such as Senna alata and Cardiospermum halicacabum [30], [62]. The FTIR spectra can be used to identify the function of the chemical generation of different compounds as shown in the Mimosa pudica and Bougainvillea spectabilis, where typical peaks were identified as alkaloids and tannins [63], [64]. These methods are augmented by colorimetric methods of total phenolic and flavonoid content measurement, which are prelude to antimicrobial potential [31], [17].
3.7.2 Major Classes of Phytochemicals and their Anti-microbial associations.
Phytochemical screening regularly finds several classes of bioactive with proven antimicrobial activity:

T

able 6. Dominant Phytochemical Classes and Their Antimicrobial Efficacy Across Medicinal Plants